ResearcherKonyang UniversityActive in the last 2 years
Young Woo Choi
Matched on ORCID iD 0000-0003-2140-1834; OpenAlex author ID A5023102070. Sources: ClinicalTrials.gov.
Their work
- Papers
- 2
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 2
- Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin leve… Co-author DOI 10.1038/s41416-023-02474-w↗
- Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum … Co-author DOI 10.1038/s41416-023-02520-7↗
Trials 1
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hong Sik Lee · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Trial A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients NCT02854072↗
- Eun Kwang Choi · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Trial A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients NCT02854072↗
- Seung Ok Lee · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Trial A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients NCT02854072↗
- Ho Gak Kim · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Trial A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients NCT02854072↗
- Ho Soon Choi · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Trial A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients NCT02854072↗
- Yong‐Tae Kim · 2 shared papers, 1 shared trial, 2015–2024 · strength 0.39
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Trial A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients NCT02854072↗
- Chang‐Hwan Park · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Jae Woo Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Eui Joo Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Mi‐Suk Park · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Y. Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Si Young Song · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Jung Hyun Jo · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Hyungsik Roger Moon · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Dong Uk Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Woo Jin Lee · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Kwang Hyuck Lee · 1 shared paper, 1 shared trial, 2015–2024 · strength 0.23
- Kwang Hyuck Lee · 1 shared paper, 2024 · strength 0.16
- Woo Jin Lee · 1 shared trial, 2015 · strength 0.06
- Gwang Ha Kim · 1 shared trial, 2015 · strength 0.06
- Jae Yong Cho · 1 shared trial, 2015 · strength 0.06
- Jae Hee Cho · 1 shared trial, 2015 · strength 0.06
- Kyong Joo Lee · 1 shared trial, 2015 · strength 0.06
- Si Young Song · 1 shared trial, 2015 · strength 0.06
- Joung-Ho Han · 1 shared trial, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.